Search for: "Eli Lilly "
Results 1821 - 1840
of 2,131
Sorted by Relevance
|
Sort by Date
20 Apr 2016, 7:28 pm
By Joy P. [read post]
13 Apr 2010, 10:26 am
Eli Lilly & Co., No. 2008-1248, 2010 WL 1007369 (Fed. [read post]
17 Mar 2011, 11:55 am
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
25 Mar 2011, 8:29 pm
" Eli Lilly & Co. v. [read post]
10 May 2012, 9:22 am
The Seventh Circuit bolstered its conclusion by reference to the preamble of the 2004 update to the FLSA regulations, which noted that administrative work includes "representing the company" and "promoting sales," two tasks that fairly describe the pharmaceutical rep's function within Eli Lilly. [read post]
5 Jan 2012, 3:10 pm
Takeda and Eli Lilly & Company jointly promoted Actos in the United States since its launch in 1999; however as of 2006, Takeda solely assumed all marketing and sales responsibilities for Actos. [read post]
4 Jan 2024, 9:42 am
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
11 Jan 2019, 4:00 am
In the UK, the Supreme Court in 2017 released its decision in Actavis UK Ltd v Eli Lilly & Co [2017] UKSC 48 which allowed for variants in claim construction. [read post]
2 Oct 2009, 7:14 am
Tax gross-ups were a contributing factor at Sandisk and Equifax, and helped fuel more than 20 percent opposition at AT&T, Agilent Technologies, AK Steel, CIT Group, and Eli Lilly. [read post]
15 Nov 2022, 11:26 am
Though much of the trolling was fairly harmless, the medical company Eli Lilly saw their stock dip following a fake announcement that they were offering insulin for free. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) (GenericsWeb) (patentcircle) Temodar (Temozolomide) – US: Teva announces parties to patent litigation regarding Barr’s US generic Temodar have entered into agreement pending resolution of Schering’s appeal to CAFC over ‘291 patent unenforceability finding (SmartBrief) Trilipix (Fenofibrate) – US: Impax Laboratories confirms challenge to Abbott and Fournier’s listed patent relating to Trilipix delayed-release capsules, 135 mg and 45 mg (SmartBrief)… [read post]
22 Mar 2010, 12:17 pm
Eli Lilly and Co. [read post]
10 Aug 2011, 7:46 pm
Eli Lilly & Co., 589 F.3d 1336, 1351 (Fed. [read post]
27 Apr 2017, 4:00 am
Eli Lilly has ruled that (like US law) the exercise of IP rights is not necessarily a defense to anti-competition rules in Canada. [read post]
25 Sep 2017, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
20 Jun 2012, 8:26 am
On the other side of the coin, Brian Barrett, Associate General Patent Counsel for Eli Lilly & Company, felt that prior user rights are mostly positive. [read post]
28 Sep 2011, 2:00 am
Armitage’s, of Eli Lilly and Company, presentation entitled ”A New 102: Reform, Not Recodification”…. [read post]
3 Jun 2012, 12:17 pm
Eli Lilly & Co. v. [read post]
9 Mar 2020, 3:19 pm
” Actavis UK Ltd v Eli Lilly and Co [2017] UKSC 48 (Lord Kitchin JSC). [read post]
6 Jul 2011, 2:21 am
One District Court has an answer: Nycomed v Tolmar (FDA Law Blog) Trizivir (Abacavir) – US: ViiV Healthcare files patent infringement complaint against Lupin in response to Para IV certification filing (Patent Docs) Welchol (Colesevelam) – US: Glenmarks settles litigation with Daiichi Sankyo, Genzyme (GenericsWeb) Xeloda (Capecitabine) – US: Hoffman-La Roche files patent infringement suits against Accord Healthcare, Teva and Roxane following Para IV certification filing (Patent… [read post]
